Mumbai, May 21 -- The scrip was listed at 79, a discount of 21.78% over the initial public offer (IPO) price. The stock was currently frozen at its upper limit of 5% over its listing price.

The counter hit a high of Rs 82.95 and a low of Rs 75.05. About 4.48 lakh shares of the company changed hands at the counter.

Accretion Pharmaceuticals' IPO was subscribed 7.31 times. The issue opened for bidding on 14 May 2025 and it closed on 16 May 2025. The price band of the IPO was set at Rs 96 to Rs 101 per share.

The IPO comprised fresh issue of 29,46,000 equity shares. The promoter and promoter group shareholding diluted to 73.14% from 100% pre-issue.

The company intends to utilize the net proceeds for capital expenditure towards the purcha...